GenMont Biotech Incorporation (TPE:3164)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.75
-0.20 (-1.11%)
Apr 29, 2026, 1:30 PM CST
-7.79%
Market Cap 1.53B
Revenue (ttm) 401.23M
Net Income (ttm) 57.20M
Shares Out 86.01M
EPS (ttm) 0.66
PE Ratio 26.89
Forward PE n/a
Dividend 0.80 (4.46%)
Ex-Dividend Date Apr 8, 2026
Volume 41,812
Average Volume 50,395
Open 17.95
Previous Close 17.95
Day's Range 17.70 - 17.95
52-Week Range 17.20 - 22.40
Beta 0.15
RSI 43.03
Earnings Date May 8, 2026

About TPE:3164

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2000
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 3164
Full Company Profile

Financial Performance

In 2025, TPE:3164's revenue was 401.23 million, an increase of 4.11% compared to the previous year's 385.37 million. Earnings were 57.20 million, a decrease of -0.09%.

Financial Statements

News

There is no news available yet.